Ropes & Gray advised TRexBio on the deal. TRexBio in a multi-year research collaboration and exclusive worldwide license agreement with Eli Lilly and Company to develop...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Scipher Medicine on the deal. Precision immunology company Scipher Medicine announced its acquisition of data, analytics and software company CrossBridge to enhance...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented CANbridge Pharmaceuticals on the deal. CANbridge Pharmaceuticals, a China-based biopharmaceutical company, announced its exclusive worldwide license agreement with UMass Chan Medical School relating...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Shoreline Equity Partners on the deal. Shoreline Equity Partners, LLC announced the closing of its second private equity fund, Shoreline Equity Partners Fund...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Two Sigma Impact on the deal. Milestone Technologies Inc., a leading global IT Services provider, announced that The Halifax Group, a middle market...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised VSS Capital Partners on the deal. VSS Capital Partners announced the closing of its VSS Structured Capital Fund IV at $530 million, well...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Advent International on the deal. Advent International closed a $175 million minority investment in TredenceInc., a data science and AI engineering company. The...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented a consortium led by Silversmith Capital Partners and Health Velocity Capital on the deal. A consortium led by Silversmith Capital Partners and...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised ImmunoGen on the deal. ImmunoGen, a leader in the field of antibody-drug conjugates for cancer treatment, announced a research collaboration with Biosion USA,...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented GHO Capital portfolio company Velocity Clinical Research on the deal. GHO Capital portfolio company Velocity Clinical Research announced the acquisition of Meridian Clinical...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised ImmunoGen on the deal. ImmunoGen, a leader in the field of antibody-drug conjugates for cancer treatment, in a clinical collaboration with Gilead...
You must be a Standard 1 Year member to access this content.
Allen & Overy and Vinge advised Intrum AB on the deal while Ropes & Gray advised the initial purchasers, including Citigroup, Goldman Sachs Bank Europe SE...
You must be a Standard 1 Year member to access this content.
